Avalyn Pharma, Inc. (AVLN)
37.39
+1.95
(+5.50%)
USD |
NASDAQ |
Sep 04, 16:00
37.00
-0.39
(-1.04%)
After-Hours: 20:00
Avalyn Pharma Market Cap : 1.658B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 1.658B |
| September 03, 2026 | 1.571B |
| September 02, 2026 | 1.577B |
| September 01, 2026 | 1.564B |
| August 31, 2026 | 1.540B |
| August 28, 2026 | 1.538B |
| August 27, 2026 | 1.619B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.694B |
| August 24, 2026 | 1.671B |
| August 21, 2026 | 1.701B |
| August 20, 2026 | 1.646B |
| August 19, 2026 | 1.728B |
| August 18, 2026 | 1.723B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.740B |
| August 13, 2026 | 1.622B |
| August 12, 2026 | 1.657B |
| August 11, 2026 | 1.572B |
| August 10, 2026 | 1.532B |
| August 07, 2026 | 1.504B |
| August 06, 2026 | 1.450B |
| August 05, 2026 | 1.419B |
| August 04, 2026 | 1.362B |
| August 03, 2026 | 1.263B |
| Date | Value |
|---|---|
| July 31, 2026 | 1.276B |
| July 30, 2026 | 1.299B |
| July 29, 2026 | 1.246B |
| July 28, 2026 | 1.232B |
| July 27, 2026 | 1.224B |
| July 24, 2026 | 1.239B |
| July 23, 2026 | 1.318B |
| July 22, 2026 | 1.273B |
| July 21, 2026 | 1.287B |
| July 20, 2026 | 1.269B |
| July 17, 2026 | 1.255B |
| July 16, 2026 | 1.138B |
| July 15, 2026 | 1.215B |
| July 14, 2026 | 1.254B |
| July 13, 2026 | 1.234B |
| July 10, 2026 | 1.244B |
| July 09, 2026 | 1.282B |
| July 08, 2026 | 1.283B |
| July 07, 2026 | 1.260B |
| July 06, 2026 | 1.226B |
| July 02, 2026 | 1.318B |
| July 01, 2026 | 1.338B |
| June 30, 2026 | 1.459B |
| June 29, 2026 | 1.374B |
| June 26, 2026 | 1.361B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 39.62M |
| CorMedix, Inc. | 654.73M |
| Eloxx Pharmaceuticals, Inc. | 60.55M |
| Cannabis Global, Inc. | 0.6564M |
| Breakthrough Chemistry, Inc. | 2.024M |
Market Cap Related Metrics
| Price to Book Value | 4.161 |
| Price | 37.39 |
| Earnings Yield | -5.64% |